The Company’s ordinary shares are listed and trade on the London Stock Exchange AIM market.

Shares in issue
36,498,269,332 Ordinary Shares of 0.000001p each.
There are no restrictions on the transfer of the company’s securities.

Significant & Directors’ Shareholdings

https://www.ambienpharmacy.org

DesignationShareholder NameAmount% Holding
SMKTNOMSINTERACTIVE INVESTOR SERVICES NOMINEES LIMITED4,136,104,86711%
PMPRINCPEEL HUNT PARTNERSHIP LIMITED3,657,079,63510%
15942HARGREAVES LANSDOWN (NOMINEES) LIMITED2,879,329,6908%
XPIDEALPUMA NOMINEES LIMITED2,474,288,8637%
SMKTISASINTERACTIVE INVESTOR SERVICES NOMINEES LIMITED2,426,338,5397%
UKOGCCNMUFG CORPORATE MARKETS TRUSTEES (NOMINEES) LIMITED1,824,912,6855%
THE BANK OF NEW YORK (NOMINEES) LIMITED1,677,225,0365%
VRAHARGREAVES LANSDOWN (NOMINEES) LIMITED1,671,752,0965%
CLIENT1BARCLAYS DIRECT INVESTING NOMINEES LIMITED1,612,197,6364%
HLMONHARGREAVES LANSDOWN (NOMINEES) LIMITED1,334,092,1764%
CFECANTOR FITZGERALD EUROPE1,198,173,4913%
IGUKCLTVIDACOS NOMINEES LIMITED1,172,192,0693%
SIPPLAWSHARE NOMINEES LIMITED1,025,934,773%
CSHGROSSROCK (NOMINEES) LIMITED983,951,7273%
TDWHSIPPINTERACTIVE INVESTOR SERVICES NOMINEES LIMITED937,978,2543%
MAXIHSDL NOMINEES LIMITED914,433,2623%

The total percentage of shares not in public hands is 10.07% defined as being beneficial holdings of shares held by shareholders holding above 10% and the directors holdings.

Last updated: 23 June 2026